2025-03-10 20:45:26
Latest Post
Syngene acquires its First Manufacturing Facility in the US 
Thermax Partners with Brazil-Based OCQ for High-Performance Chemicals
BEL receives orders worth Rs.843 Crore
RVNL signed MoU with M/s Abhinava Strategic Partners Pvt Ltd
Gensol Engineering promoter demonstrates unwavering commitment with INR 29 Cr. Equity Infusion
Stock Report
Genesys International Corporation Ltd consolidated Q2 FY2023-24 loss at Rs. 3.43 crore
Posted On : 2023-11-05 15:44:26( TIMEZONE : IST )
Genesys International Corporation Limited has reported Consolidated financial results for the period ended September 30, 2023.
Financial Results (Q2 FY2024) - QoQ Comparison
The company has reported total income of Rs. 34.2948 crores during the period ended September 30, 2023 as compared to Rs. 35.4727 crores during the period ended June 30, 2023.
The company has posted net profit / (loss) of Rs. -3.4365 crores for the period ended September 30, 2023 as against net profit / (loss) of Rs. -5.4640 crores for the period ended June 30, 2023.
The company has reported EPS of Rs. -0.49 for the period ended September 30, 2023 as compared to Rs. -1.40 for the period ended June 30, 2023.
| Financials | Q2 FY2024 | Q1 FY2024 | % Change |
| Total Income | ₹ 34.2948 crs | ₹35.4727 crs |  -3.32% |
| Net Profit | ₹-3.4365 crs | ₹-5.4640 crs |  37.11% |
| EPS | ₹-0.49 | ₹-1.40 | 65.00% |
Financial Results (Q2 FY2024) - YoY Comparison
The company has reported total income of Rs. 34.2948 crores during the period ended September 30, 2023 as compared to Rs.39.3090 crores during the period ended September 30, 2022.
The company has posted net profit / (loss) of Rs.-3.4365 crores for the period ended September 30, 2023 as against net profit / (loss) of Rs.3.2295 crores for the period ended September 30, 2022.
The company has reported EPS of Rs.-0.49 for the period ended September 30, 2023 as compared to Rs.1.36 for the period ended September 30, 2022.
| Financials | Q2 FY2024 | Q2 FY2023 | % Change |
| Total Income | ₹ 34.2948 crs | ₹39.3090 crs | -12.76% |
| Net Profit | ₹-3.4365 crs | ₹3.2295 crs | -206.41% |
| EPS | ₹-0.49 | ₹1.36 | -136.03% |
Financial Results (Half Year Ended FY2024) - YoY Comparison
The company has reported total income of Rs.69.7675 crores during the 6 Months period ended September 30, 2023 as compared to Rs.83.3755 crores during the 6 Months period ended September 30, 2022.
The company has posted net profit / (loss) of Rs.-8.9005 crores for the 6 Months period ended September 30, 2023 as against net profit / (loss) of Rs.5.1974 crores for the 6 Months period ended September 30, 2022.
The company has reported EPS of Rs.-1.30 for the 6 Months period ended September 30, 2023 as compared to Rs.2.55 for the 6 Months period ended September 30, 2022.
| Financials | Half Year Ended FY2024 | Half Year Ended FY2023 | % Change |
| Total Income | ₹69.7675 crs | ₹83.3755 crs | -16.32% |
| Net Profit | ₹-8.9005 crs | ₹5.1974 crs | -271.25% |
| EPS | ₹-1.30 | ₹2.55 | -150.98% |
Shares of Genesys International Corporation Limited was last trading in BSE at Rs. 320.00 as compared to the previous close of Rs. 321.20. The total number of shares traded during the day was 1761 in over 163 trades.
The stock hit an intraday high of Rs. 328.00 and intraday low of 313.00. The net turnover during the day was Rs. 568612.00.
